Healthcare advocacy groups and other stakeholders are speaking out against the Trump administration’s decision to allow short-term healthcare insurance plans to extend up to three years.

More than 200 health services deals were reported in the second quarter of 2018, continuing the ongoing streak of mergers and acquisitions in the sector, according to PricewaterhouseCoopers.

Male breast cancer is rare, making up less than 1 percent of all breast cancers. However, radiologists and all imaging professionals must have as much up-to-date information on the detection and treatment of male breast cancer as possible.

Dozens of research papers and large-scale trials are evidence that interest in immunotherapy is growing among oncologists, according to an editorial published in the International Journal of Radiation Oncology • Biology • Physics, but that research won’t be able to grow without universal adherence to quality assurance (QA) standards for radiation therapy. For now, at least, that’s not the reality.

Healthcare advocacy groups expressed concern with the Trump administration’s final rule on short-term insurance plans, saying the decision to extend those limited plans for up to three years could destabilize other insurance markets and leave patients covered by such plans exposed to catastrophic costs.

Hospices will see a 1.8 percent, or $340 million, payment increase in 2019 after CMS finalized its annual payment update.

Bayer has shot back after a documentary aired on Netflix took aim its controversial birth control implant, Essure.

The family of Melanie Smith, a mother of two who died in 2015 at the age of 40, was awarded $3.5 million by a jury this week after an emergency room (ER) physician reportedly failed to diagnose Smith’s stroke in time, leading to her death, the Staunton News Leader has reported.